Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer. Xu L, Zhao B, Butler W, Xu H, et al. Oncogene 2022 Jan 20. pii: 10.1038/s41388-021-02155.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xu L, Zhao B, Butler W, Xu H, et al. Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer. Oncogene 2022 Jan 20. pii: 10.1038/s41388-021-02155.
PMID: 35046532